Cevipabulin-tubulin complex reveals a novel agent binding site on α-tubulin with tubulin degradation effect

Author:

Yang Jianhong1ORCID,Yu Yamei1ORCID,Li Yong1ORCID,Yan Wei1ORCID,Ye Haoyu1,Niu Lu1,Tang Minghai1,Wang Zhoufeng2ORCID,Yang Zhuang1,Pei Heying1ORCID,Wei Haoche1,Zhao Min1ORCID,Wen Jiaolin1,Yang Linyu1,Ouyang Liang1,Wei Yuquan1,Chen Qiang1ORCID,Li Weimin2ORCID,Chen Lijuan1ORCID

Affiliation:

1. Laboratory of Natural and Targeted Small Molecule Drugs, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu 610041, China.

2. Department of Respiratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.

Abstract

A novel binding site on α-tubulin shows promise as a target for a new generation of anticancer drugs.

Funder

National Natural Science Foundation of China

West China Hospital, Sichuan University

Sichuan Science and Technology Program Grants

Post Doctor Research Project Sichuan University

China Postdoctoral Science Foundation Grants

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3